HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis.

AbstractUNLABELLED:
Experience with early corticosteroid withdrawal (CSWD) in renal transplant recipients with focal segmental glomerulosclerosis (FSGS) has not been previously reported. Since corticosteroids are used to treat primary FSGS, concern exists as to whether early CSWD regimens will be associated with an increased risk of FSGS recurrence posttransplant. The purpose of the present study was to evaluate the results of early CSWD in FSGS recipients and compare these results to a historic control group of FSGS patients who underwent renal transplantation under corticosteroid-based immunosuppression.
METHODS:
Forty-three patients with FSGS underwent renal transplantation with early CSWD. Results in these patients were compared to FSGS patients that underwent renal transplantation with chronic corticosteroid therapy. All rejection episodes were biopsy proven with grading by Banff criteria. Statistical analyses included Student's t test and chi square tests.
RESULTS:
Results in 43 patients with a median follow-up of 569 days were analyzed and compared to control patients. There was no significant difference in recurrent FSGS, time to recurrence, or graft loss.
CONCLUSION:
CSWD does not increase risk for recurrence of FSGS. These observations indicate that ECSW can be achieved in FSGS patients, thereby affording them the benefits of steroid elimination.
AuthorsR Boardman, J Trofe, R Alloway, C Rogers, P Roy-Chaudhury, M Cardi, S Safdar, B Groene, J Buell, M Hanaway, M Thomas, W Alexander, R Munda, E S Woodle
JournalTransplantation proceedings (Transplant Proc) Vol. 37 Issue 2 Pg. 817-8 (Mar 2005) ISSN: 0041-1345 [Print] United States
PMID15848542 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Adrenal Cortex Hormones
  • Creatinine
Topics
  • Adrenal Cortex Hormones (administration & dosage, therapeutic use)
  • Adult
  • Creatinine (blood)
  • Drug Administration Schedule
  • Follow-Up Studies
  • Glomerulosclerosis, Focal Segmental (epidemiology, pathology)
  • Humans
  • Kidney Transplantation (pathology)
  • Middle Aged
  • Recurrence
  • Risk Factors
  • Time Factors
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: